Avian influenza
MONDO:0018695Infection of domestic and wild fowl and other birds with influenza A virus. Avian influenza usually does not sicken birds, but can be highly pathogenic and fatal in domestic poultry.
73 clinical trials for this condition and its sub-types, 15 tagged with Avian influenza itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
New mRNA bird flu vaccine enters human testing
Vaccine CompletedThis early-stage study tests a new mRNA vaccine designed to protect against avian influenza (bird flu) in 80 healthy adults aged 18-49. The vaccine uses mRNA technology to teach the body to recognize and fight the H5 flu virus. The main goal is to check the vaccine's safety and s…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 13:07 UTC
-
New bird flu booster shot shows promise in early trial
Vaccine CompletedThis study tested a booster vaccine for H5N6 bird flu in about 260 adults. Some had previously received an H5N1 bird flu vaccine, while others had not. The goal was to see if the booster was safe and triggered a strong immune response. Participants received one or two doses of th…
Phase 2 • Sponsor: Seqirus • Aim: Vaccine
Last updated Jun 27, 2026 12:33 UTC
-
New mRNA vaccine targets bird flu pandemic threat
Vaccine CompletedThis study tested a new mRNA vaccine designed to protect against H5 pandemic flu strains. Researchers gave 276 healthy adults one of three doses or a placebo to check safety and immune response. The goal is to find the right dose for future studies.
Phase 1/2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jun 27, 2026 12:23 UTC
-
Needle-Free patch could protect against bird flu
Vaccine CompletedThis study tested a new vaccine for H7N9 bird flu, given through a small patch with tiny needles instead of a shot. Researchers wanted to see if it was safe and how the body reacted. The trial involved 267 healthy adults aged 18 to 50, who received two doses of the vaccine either…
Phase 1 • Sponsor: Vaxxas Pty Ltd • Aim: Vaccine
Last updated Jun 27, 2026 12:01 UTC
-
New mRNA bird flu vaccine shows promise in early trials
Vaccine CompletedThis study tested a new mRNA vaccine designed to protect against a potential pandemic of H5 bird flu. Nearly 1,000 healthy adults aged 18 to 85 received different doses to find the safest and most effective one. Researchers monitored side effects like pain, fever, and fatigue, an…
Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Jun 27, 2026 09:02 UTC